Post-Marketing Surveillance of Long-Term Observation of Gliadel Wafer-Investigation of Vital Prognosis in Patients With High Grade Glioma

Eisai Co., Ltd.507 enrolled

Overview

The objective of this study is to determine the survival status of patients enrolled in study GLI01S (all-case observational study).

Study Type

OBSERVATIONAL

Enrollment

507

Conditions

Malignant Glioma

Interventions

No interventionOTHER

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion criteria: * Malignant Glioma, patients enrolled in study GLI01S. Exclusion criteria: * Corresponding to contraindication of Gliadel. * Not applicable to indications of Gliadel.

Locations (2)

Unnamed facility

Osaka, Japan

Unnamed facility

Tokyo, Japan

Outcomes

Primary Outcomes

Survival rate

Survival rate of subjects measured up to 3 year after implantation

Time frame: Up to 3 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.